David Shaw’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-235,175
| Closed | -$2.9M | – | 4877 |
|
|
2024
Q4 | $2.9M | Sell |
235,175
-430,331
| -65% | -$4.93M | ﹤0.01% | 2422 |
|
|
2024
Q3 | $7.57M | Buy |
665,506
+247,129
| +59% | +$2.48M | 0.01% | 1623 |
|
|
2024
Q2 | $2.99M | Buy |
418,377
+250,068
| +149% | +$1.91M | ﹤0.01% | 2263 |
|
|
2024
Q1 | $1.13M | Buy |
168,309
+12,001
| +8% | +$82.6K | ﹤0.01% | 3015 |
|
|
2023
Q4 | $1.02M | Buy |
156,308
+51,680
| +49% | +$333K | ﹤0.01% | 3128 |
|
|
2023
Q3 | $988K | Buy |
+104,628
| New | +$1.26M | ﹤0.01% | 3068 |
|
|
2023
Q2 | – | Sell |
-23,479
| Closed | -$440K | – | 4651 |
|
|
2023
Q1 | $440K | Buy |
+23,479
| New | +$386K | ﹤0.01% | 3613 |
|
|
2021
Q4 | – | Sell |
-55,521
| Closed | -$1.2M | – | 5782 |
|
|
2021
Q3 | $1.2M | Buy |
55,521
+28,200
| +103% | +$681K | ﹤0.01% | 3460 |
|
|
2021
Q2 | $701K | Sell |
27,321
-28,063
| -51% | -$599K | ﹤0.01% | 3828 |
|
|
2021
Q1 | $1.01M | Sell |
55,384
-3,214
| -5% | -$53.4K | ﹤0.01% | 3101 |
|
|
2020
Q4 | $676K | Buy |
+58,598
| New | +$536K | ﹤0.01% | 3245 |
|
|
2020
Q2 | – | Sell |
-25,332
| Closed | -$129K | – | 4300 |
|
|
2020
Q1 | $129K | Sell |
25,332
-168,704
| -87% | -$1.02M | ﹤0.01% | 3748 |
|
|
2019
Q4 | $1.49M | Buy |
+194,036
| New | +$1.13M | ﹤0.01% | 2699 |
|
|
2019
Q2 | – | Sell |
-14,493
| Closed | -$62K | – | 3923 |
|
|
2019
Q1 | $62K | Hold |
14,493
| – | – | ﹤0.01% | 3509 |
|
|
2018
Q4 | $59K | Buy |
14,493
+4,444
| +44% | +$23.2K | ﹤0.01% | 3676 |
|
|
2018
Q3 | $69K | Buy |
+10,049
| New | +$59.6K | ﹤0.01% | 3642 |
|
|
2016
Q4 | – | Sell |
-91,280
| Closed | -$275K | – | 3642 |
|
|
2016
Q3 | $275K | Buy |
91,280
+32,645
| +56% | +$87.7K | ﹤0.01% | 3084 |
|
|
2016
Q2 | $149K | Buy |
58,635
+34,716
| +145% | +$96.8K | ﹤0.01% | 3214 |
|
|
2016
Q1 | $70K | Buy |
+23,919
| New | +$128K | ﹤0.01% | 3310 |
|
|
2015
Q3 | – | Sell |
-9,174
| Closed | -$84K | – | 3939 |
|
|
2015
Q2 | $84K | Buy |
+9,174
| New | +$88.2K | ﹤0.01% | 3665 |
|
|
2014
Q3 | – | Sell |
-4,100
| Closed | -$54K | – | 4431 |
|
|
2014
Q2 | $54K | Buy |
+4,100
| New | +$51.7K | ﹤0.01% | 4105 |
|
Other funds holding CDMO
David Shaw's CDMO Position: Q1 2025 in Review
David Shaw sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 235,175 shares — an estimated $2.9M sold.
David Shaw first reported a position in CDMO in Q2 2014 and held it in 21 quarters. The position peaked at $7.57M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- David Shaw reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- David Shaw sold 235,175 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2.9M.
- David Shaw first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2014 and held it in 21 quarters.
- David Shaw's Avid Bioservices, Inc. Common Stock position peaked at $7.57M in Q3 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.